Global Antibody-drug Conjugates Market Insights and Forecast to 2027

Global Antibody-drug Conjugates Market Insights and Forecast to 2027

  • QYResearch
  • May 2021
  • Pharmaceutical
  • 113 pages

Report Description

Antibody-drug Conjugates market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Antibody-drug Conjugates market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
Adcetris
Kadcyla

Segment by Application
Breast Cancer
Lymphoma

By Company
ImmunoGen
Seattle Genetics
Roche
Takeda

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia

Have query on this report?

Make an Enquiry
1 Study Coverage
1.1 Antibody-drug Conjugates Product Introduction
1.2 Market by Type
1.2.1 Global Antibody-drug Conjugates Market Size Growth Rate by Type
1.4.2 Adcetris
List of Tables
Table 1. Global Antibody-drug Conjugates Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Adcetris
Table 3. Major Manufacturers of Kadcyla
Table 4. Global Antibody-drug Conjugates Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 5. Global Antibody-drug Conjugates Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)

Success Stories

Our Clients